AGAP2 and central nervous system cancer: However, based on its prevalence as an oncogene in previous bioinformatics analysis related‐literature reports,71, 72 combined with the results validated in our subsequent experiments, AGAP2‐AS1 is considered to be a risk lncRNA for glioma, and the result of CGGA is considered to be confounded by its small sample size.